Hiroaki Kanda
Impact in
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
- Oncology 33
- Cancer-related Molecular Pathways 7
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Yuichi Ishikawa (11 shared papers)Eiji Hara (2 shared papers)Naoko Ohtani (2 shared papers)Seidai Sato (2 shared papers)Koji Atarashi (1 shared paper)Hidetoshi Morita (1 shared paper)Seiichi Oyadomari (1 shared paper)Kenya Honda (1 shared paper)
- Journals
- Cancer Science (6 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (5 papers)Molecular Carcinogenesis (4 papers)Scientific Reports (3 papers)PLoS ONE (3 papers)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Hiroaki Kanda
88 papers receiving 3.9k citations
Hiroaki Kanda's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 1.0k
- Cancer Research 553
- Hepatology 237
- Molecular Biology 1.9k
- Aging 48
Countries citing papers authored by Hiroaki Kanda
This map shows the geographic impact of Hiroaki Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kanda more than expected).
Fields of papers citing papers by Hiroaki Kanda
This network shows the impact of papers produced by Hiroaki Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kanda. The network helps show where Hiroaki Kanda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroaki Kanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome Hit paper breakdown → | 2013 | 1713 |
| 2 | 2006 | 337 | |
| 3 | 2005 | 285 | |
| 4 | 2018 | 212 | |
| 5 | 2008 | 192 | |
| 6 | GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma Hit paper breakdown → | 2022 | 117 |
| 7 | 2001 | 112 | |
| 8 | 2015 | 62 | |
| 9 | 2015 | 53 | |
| 10 | Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN in equilibrium with C57BL/6N chimeric mice. | 1991 | 49 |
| 11 | 1998 | 44 | |
| 12 | 1993 | 44 | |
| 13 | Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. | 1993 | 41 |
| 14 | 1993 | 38 | |
| 15 | 2008 | 33 | |
| 16 | 2018 | 31 | |
| 17 | 2019 | 28 | |
| 18 | 2014 | 24 | |
| 19 | 2003 | 23 | |
| 20 | 2018 | 22 |
About Hiroaki Kanda
Hiroaki Kanda is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology and Surgery, having authored 100 papers that have together received 4.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (19 papers), Bone Tumor Diagnosis and Treatments (9 papers), Cancer-related Molecular Pathways (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Oral and Maxillofacial Pathology (6 papers), Esophageal Cancer Research and Treatment (5 papers) and Soft tissue tumor case studies (5 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (553 citations), Hepatology (237 citations), Molecular Biology (1.9k citations) and Aging (48 citations). Hiroaki Kanda has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Yuichi Ishikawa, Eiji Hara, Naoko Ohtani, Seidai Sato, Koji Atarashi, Hidetoshi Morita, Seiichi Oyadomari, Kenya Honda, Yoichiro Iwakura and Tze Mun Loo. Their work appears in journals such as Cancer Science, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Molecular Carcinogenesis, Scientific Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.